Patanjali Misleading Medicine Ads Case: Next Date Of Hearing On January 15

New Delhi: The Supreme Court heard on December 13 the plea of the Indian Medical Association (IMA) regarding misleading claims and advertisements against “Allopathic” medicine.

A Bench comprising Justice Abhay Oka and Justice Pankaj Mithal asked amicus Curia Shadhan Farast to give a brief note on the issues involved in the case, details of orders passed so far and compliances made to these orders. The next date of hearing ws set for January 15.

Since it is a new bench, the judges want to understand the matter, the bench said.

The case pertains to a petition filed by the Indian Medical Association seeking action against Patanjali for allegedly conducting a smear campaign against modern medicine and the Covid-19 vaccination drive.

The top court had taken action against Patanjali and the Ramdev-Balkrishna duo for disobeying its orders and asked it to publish advertisements in newspapers apologising for the same. At the same time, it also pulled up certain doctors practising modern medicine.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records